Bicycle Therapeutics Plc Asset Turnover Ratio (BCYC), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Bicycle Therapeutics Plc  (NASDAQ: BCYC)
 

Bicycle Therapeutics Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Bicycle Therapeutics Plc asset turnover ratio, the ability of Bicycle Therapeutics Plc's assets to generate revenue in the third quarter 2026, increased sequentially to 0.13 in the third quarter (Sep 30 2026), a new company high.

Within sector 162 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 2735 to 3289.

Asset Turnover Ratio Definition



BCYC Asset Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Asset Change -25.45 % -26.71 % -25.68 % -24.47 % -22.99 %
Y / Y Revenue Change 190.24 % -78.46 % -91.11 % 1193.28 % 338.49 %
Asset Turnover Ratio (TTM) 0.13 0.09 0.09 0.09 0.03
BCYC's Total Ranking # 3289 # 2735 # 2848 # 16 #
Seq. Asset Change -6.5 % -7.03 % -9.09 % -5.66 % -8.08 %
Seq. Revenue Change 5314.47 % -29.09 % -98.15 % 308.68 % 301.85 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 163
Healthcare Sector # 483
Overall Market # 3289

Asset Turnover Ratio Statistics
High Average Low
0.13 0.06 0.02
(Dec 31 2019)   (Jun 30 2025)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Jazz Pharmaceuticals Plc  0.41 $ 4,718.126  Millions$ 11,649.385  Millions
Iovance Biotherapeutics inc   0.40 $ 378.983  Millions$ 936.395  Millions
Zai Lab Limited  0.40 $ 441.727  Millions$ 1,091.702  Millions
Regeneron Pharmaceuticals Inc   0.40 $ 16,896.200  Millions$ 41,890.825  Millions
Bausch and Lomb Corp  0.39 $ 5,418.000  Millions$ 13,905.000  Millions
Ptc Therapeutics inc   0.38 $ 1,155.554  Millions$ 3,056.516  Millions
Regenxbio Inc   0.37 $ 153.911  Millions$ 411.896  Millions
Beta Bionics Inc   0.37 $ 127.899  Millions$ 342.326  Millions
Rxsight Inc   0.37 $ 122.088  Millions$ 327.231  Millions
Sotera Health Company  0.37 $ 1,230.250  Millions$ 3,298.320  Millions
Biomarin Pharmaceutical Inc  0.37 $ 3,655.127  Millions$ 9,869.428  Millions
Intelligent Bio Solutions Inc   0.37 $ 4.495  Millions$ 12.169  Millions
Xilio Therapeutics Inc   0.36 $ 55.010  Millions$ 151.815  Millions
Aquestive Therapeutics Inc   0.35 $ 48.837  Millions$ 138.245  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,020.000  Millions$ 40,171.750  Millions
Profound Medical Corp   0.35 $ 23.627  Millions$ 67.868  Millions
Biogen Inc   0.33 $ 10,297.300  Millions$ 30,765.825  Millions
Krystal Biotech Inc   0.32 $ 470.025  Millions$ 1,454.366  Millions
Hyperfine Inc   0.31 $ 18.537  Millions$ 59.098  Millions
Orasure Technologies Inc  0.31 $ 116.113  Millions$ 373.089  Millions
Pfizer Inc  0.31 $ 63,625.000  Millions$ 205,363.250  Millions
Cardiff Lexington Corporation  0.30 $ 9.066  Millions$ 30.160  Millions
Ionis Pharmaceuticals Inc   0.30 $ 960.091  Millions$ 3,220.224  Millions
Adc Therapeutics Sa  0.30 $ 84.873  Millions$ 287.472  Millions
Sonida Senior Living Inc   0.29 $ 638.130  Millions$ 2,170.454  Millions
Fulgent Genetics Inc   0.29 $ 329.873  Millions$ 1,134.512  Millions
Waters Corporation  0.29 $ 5,611.362  Millions$ 19,618.388  Millions
Orchestra Biomed Holdings Inc   0.28 $ 31.206  Millions$ 109.738  Millions
Amarin Corp Plcuk  0.27 $ 176.609  Millions$ 643.746  Millions
Repligen Corp  0.27 $ 805.610  Millions$ 2,939.265  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.